Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine.
D000701:Analgesics, Opioid / Q000009:adverse effects*; D000928:Antidepressive Agents / Q000009:adverse effects*; D003511:Cyclohexanols / Q000009:adverse effects*; D003866:Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008803:Mianserin / Q000009:adverse effects* / Q000031:analogs & derivatives*; D008875:Middle Aged; D000078785:Mirtazapine; D010146:Pain / Q000188:drug therapy*; D019338:Polypharmacy; D020230:Serotonin Syndrome / Q000139:chemically induced*; D014147:Tramadol / Q000009:adverse effects*; D000069470:Venlafaxine Hydrochloride
D000701:Analgesics, Opioid; D000928:Antidepressive Agents; D003511:Cyclohexanols; D008803:Mianserin; D014147:Tramadol; D000069470:Venlafaxine Hydrochloride; D000078785:Mirtazapine